drugset / Trial / NCT04918862

A COMPARATIVE STUDY BETWEEN 1MG AND 3 MG OF GRANISETRON IN THE PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING IN STRABISMUS OPHTHALMIC SURGERIES DURING GENERAL ANESTHESIA

NCT04918862

RandomizedParallel-groupSingle-blindPrevention

Summary

Investigators aim to determine the optimal dose of granisetron in strabismus ophthalmic surgeries under general anesthesia to prevent postoperative nausea and vomiting

Timeline

Start
2021-01-08
Primary completion
2021-05-09
Completion
2021-05-18

Drugs

EvaluationDrugModalityDoseRoute
Comparator Granisetron Other / unclassified 1 mg
Comparator Granisetron Other / unclassified 3 mg

Indications

No indication recorded.